// App-Quantinova.ai

: Cost to Treat Newly Diagnosed Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Analysis

Researchers

Presenter

  • Anem Waheed

Principal Investigators

  • Denise Clayton

  • Jason Shafrin

  • Frank Li

  • Yulin Shi

  • Lincy Geevarghese

  • Glorian P. Yen

Medical Centers

  • MGH Cancer Center, Hematology, Massachusetts General Hospital/Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • Novartis AG

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved